Literature DB >> 28879535

Hypercalcemia: a consultant's approach.

Ari Auron1, Uri S Alon2.   

Abstract

Due to their daily involvement in mineral metabolism, nephrologists are often asked to consult on children with hypercalcemia. This might become even more pertinent when the hypercalcemia is associated with acute kidney injury and/or hypercalciuria and renal calcifications. The best way to assess the severity of hypercalcemia is by measurement of plasma ionized calcium, and if not available by adjusting serum total calcium to albumin concentration. The differential diagnosis of the possible etiologies of the disturbance in the mineral homeostasis starts with the assessment of serum parathyroid hormone concentration, followed by that of vitamin D metabolites in search of both genetic and acquired etiologies. Several tools are available to acutely treat hypercalcemia with the current main components being fluids, loop diuretics, and antiresorptive agents. This review will address the pathophysiologic mechanisms, clinical manifestations, and treatment modalities involved in hypercalcemia.

Entities:  

Keywords:  Acute kidney injury; Bisphosphonates; Calcitriol; PTH-related peptide; Parathyroid hormone; Vitamin D

Mesh:

Substances:

Year:  2017        PMID: 28879535     DOI: 10.1007/s00467-017-3788-z

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  85 in total

1.  Identification of 25-hydroxyvitamin D3 1alpha-hydroxylase gene expression in macrophages.

Authors:  T Monkawa; T Yoshida; M Hayashi; T Saruta
Journal:  Kidney Int       Date:  2000-08       Impact factor: 10.612

Review 2.  Hypercalcemia in children and adolescents.

Authors:  Steven A Lietman; Emily L Germain-Lee; Michael A Levine
Journal:  Curr Opin Pediatr       Date:  2010-08       Impact factor: 2.856

3.  Normalization of serum calcium by cinacalcet in a patient with hypercalcaemia due to a de novo inactivating mutation of the calcium-sensing receptor.

Authors:  H J L M Timmers; M Karperien; N A T Hamdy; H de Boer; A R M M Hermus
Journal:  J Intern Med       Date:  2006-08       Impact factor: 8.989

4.  Maternal and neonatal hyperparathyroidism as a consequence of maternal renal tubular acidosis.

Authors:  R C Savani; F Mimouni; R C Tsang
Journal:  Pediatrics       Date:  1993-03       Impact factor: 7.124

5.  The A, B, C, D of hypercalcaemia in Down syndrome.

Authors:  Huy A Tran; Shuzhen Song; Patricia A Crock; John Mattes; Keith Howard
Journal:  BMJ Case Rep       Date:  2009-03-05

6.  Resolution of medullary nephrocalcinosis in children with metabolic bone disorders.

Authors:  Ari Auron; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2005-06-23       Impact factor: 3.714

7.  Hypercalcemia, hypercalciuria and nephrocalcinosis in a breast-fed term newborn: a rare presentation.

Authors:  Issa A Hazza; Manahil S Ghandour; Reham I Almardini; Rana E Haddad; Ghazi M Salaita
Journal:  Saudi J Kidney Dis Transpl       Date:  2014-07

8.  Severe hypercalcemic crisis in an infant with idiopathic infantile hypercalcemia caused by mutation in CYP24A1 gene.

Authors:  Filip Fencl; Květa Bláhová; Karl Peter Schlingmann; Martin Konrad; Tomáš Seeman
Journal:  Eur J Pediatr       Date:  2012-09-22       Impact factor: 3.183

9.  Hypercalcemia and nephrocalcinosis in patients with congenital lactase deficiency.

Authors:  T Saarela; S Similä; M Koivisto
Journal:  J Pediatr       Date:  1995-12       Impact factor: 4.406

10.  Severe hypercalcemia complicating recovery of acute kidney injury due to rhabdomyolysis.

Authors:  Lisa Aimee Hechanova; Seyed-Ali Sadjadi
Journal:  Am J Case Rep       Date:  2014-09-14
View more
  6 in total

1.  A toddler with severe hypercalcemia and pyelonephritis: Answers.

Authors:  Joseph Wilbanks; Jessica Hillyer; Faris Hashim; David Sas; Christian Hanna
Journal:  Pediatr Nephrol       Date:  2020-07-20       Impact factor: 3.714

Review 2.  Use of calcimimetics in children with normal kidney function.

Authors:  Judith Sebestyen VanSickle; Tarak Srivastava; Uri S Alon
Journal:  Pediatr Nephrol       Date:  2018-03-19       Impact factor: 3.714

3.  Impact of admission serum ionized calcium levels on risk of acute kidney injury in hospitalized patients.

Authors:  Charat Thongprayoon; Wisit Cheungpasitporn; Api Chewcharat; Michael A Mao; Tarun Bathini; Saraschandra Vallabhajosyula; Sorkko Thirunavukkarasu; Kianoush B Kashani
Journal:  Sci Rep       Date:  2020-07-23       Impact factor: 4.379

4.  Severe hypercalcemia and a pelvic brown tumor in an adolescent with primary hyperparathyroidism: a case report.

Authors:  O Legault; M Inman; N Moolman; S Wiebe; A Poulin; M A Nour
Journal:  BMC Pediatr       Date:  2020-12-05       Impact factor: 2.125

5.  Mechanisms of acute hypercalcemia in pediatric patients following the interruption of Denosumab.

Authors:  A Deodati; D Fintini; E Levtchenko; M Rossi; G Ubertini; H Segers; G Battafarano; M Cappa; A Del Fattore
Journal:  J Endocrinol Invest       Date:  2021-07-03       Impact factor: 4.256

Review 6.  Genetic causes of neonatal and infantile hypercalcaemia.

Authors:  Caroline M Gorvin
Journal:  Pediatr Nephrol       Date:  2021-05-14       Impact factor: 3.714

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.